Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Hollema

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Maturitas|November 15, 2011
Model of care for women at increased risk of breast and ovarian cancerGeertruida H De Bock, Jan Willem Hesselink, Carriene Roorda, et al.
Genes, Chromosomes & Cancer|June 15, 2010
Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposureRenske Fles, Wilhelmina E Hoogendoorn, Inge Platteel, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 15, 2006
An overview of innovative techniques to improve cervical cancer screeningEsther R Nijhuis, Nathalie Reesink-Peters, G Bea A Wisman, et al.
Gynecologic Oncology|February 27, 2009
Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancerNinke Leffers, Marloes J M Gooden, Anna A Mokhova, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2015
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)W Glenn McCluggage, Meagan J Judge, Blaise A Clarke, et al.
Gynecologic Oncology|February 22, 2005
Lymphvascular space involvement: an independent prognostic factor in endometrial cancerJustine M Briët, Harry Hollema, Nathalie Reesink, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpressionRenee Vermeij, Geertruida H de Bock, Ninke Leffers, et al.
Rheumatology (Oxford, England)|February 12, 2020
Vaginal dryness in primary Sjögren's syndrome: a histopathological case-control studyJolien F van Nimwegen, Karin van der Tuuk, Silvia C Liefers, et al.
Cancer Immunology, Immunotherapy : CII|September 16, 2008
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancerNinke Leffers, Marloes J M Gooden, Renske A de Jong, et al.
Cancer Science|October 11, 2020
Association of homozygous variants of STING1 with outcome in human cervical cancerJoyce M Lubbers, Bart Koopman, Jessica M de Klerk-Sluis, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Maturitas|November 15, 2011
Model of care for women at increased risk of breast and ovarian cancerGeertruida H De Bock, Jan Willem Hesselink, Carriene Roorda, et al.
Genes, Chromosomes & Cancer|June 15, 2010
Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposureRenske Fles, Wilhelmina E Hoogendoorn, Inge Platteel, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 15, 2006
An overview of innovative techniques to improve cervical cancer screeningEsther R Nijhuis, Nathalie Reesink-Peters, G Bea A Wisman, et al.
Gynecologic Oncology|February 27, 2009
Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancerNinke Leffers, Marloes J M Gooden, Anna A Mokhova, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2015
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)W Glenn McCluggage, Meagan J Judge, Blaise A Clarke, et al.
Gynecologic Oncology|February 22, 2005
Lymphvascular space involvement: an independent prognostic factor in endometrial cancerJustine M Briët, Harry Hollema, Nathalie Reesink, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpressionRenee Vermeij, Geertruida H de Bock, Ninke Leffers, et al.
Rheumatology (Oxford, England)|February 12, 2020
Vaginal dryness in primary Sjögren's syndrome: a histopathological case-control studyJolien F van Nimwegen, Karin van der Tuuk, Silvia C Liefers, et al.
Cancer Immunology, Immunotherapy : CII|September 16, 2008
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancerNinke Leffers, Marloes J M Gooden, Renske A de Jong, et al.
Cancer Science|October 11, 2020
Association of homozygous variants of STING1 with outcome in human cervical cancerJoyce M Lubbers, Bart Koopman, Jessica M de Klerk-Sluis, et al.
Pageof 14